Construction and 2026 Renovation of Cancer Genome Diagnosis Support System

Sole-source notice

Japanese title: がんゲノム診療支援システムの構築業務2026年度改修1式

Medical Healthcare Software and Information Systems
About this page
This page is based on the official tender notice and presents information processed, translated, and edited by JBid.

Overview

This procurement is for the construction and 2026 fiscal year renovation of a cancer genome diagnosis support system by the National Cancer Center. The contract will be awarded through single tendering to Fujitsu Japan Ltd. due to absence of competition for technical reasons. The contract award is expected on November 27, 2026.

Key Details

  • Source: Kanpo
  • Notice type: Sole-source notice
  • Publication date: October 23, 2026
  • Procuring entity:
  • Planned contract date: November 27, 2026
  • Intended vendor: Fujitsu Japan Ltd.
  • Status: Active
  • Technology relevance: Possible
  • Business-action likelihood: Low – Single tendering to Fujitsu Japan Ltd. due to absence of competition for technical reasons indicates limited opportunity for new entrants.

Official Notice

Official Source

Kanpo, Japan's official government gazette, in which legally required public procurement notices are formally published.

  • Source: Kanpo, Government Procurement Notice Edition
  • Official category: Sole-source procurement notice
  • Publication date: October 23, 2026
  • Publication: Kanpo, pages 39

Full English Translation

The following English translation was prepared from the original Japanese notice published in Kanpo. Where an official English summary appears in the Kanpo publication, it was used only for verification; the translation below is based on the Japanese source text.

Notice of single tendering procedures is hereby announced as follows. Date: October 23, 2026. Procuring entity: National Cancer Center, Director MANO Hiroyuki. Procurement agency number: 819. Location number: 12. No. 68.
1 Procurement details:
(1) Item classification numbers 71, 27.
(2) Procurement subject and quantity: Construction work for cancer genome diagnosis support system 2026 fiscal year renovation 1 set.
2 Scheduled date of single tendering contract:
November 27, 2026.
3 Reason for single tendering under the Agreement on Government Procurement:
b Absence of competition for technical reasons.
4 Name of the prospective contracting party:
Fujitsu Japan Ltd.
5 Contact department:
Finance and Accounting Division, National Cancer Center Hospital East, Kashiwanoha 6-5-1, Kashiwa City, Chiba Prefecture, 277-8577, Japan. Phone: 04-7133-1111.
Show original Japanese notice

随意契約に関する公示

次のとおり随意契約について公示します。令和8年10月23日国立研究開発法人国立がん研究センター理事長間野博行◎調達機関番号819 ◎所在地番号12〇第68号1 調達内容(1)品目分類番号 71、27(2)調達件名及び数量がんゲノム診療支援システムの構築業務2026年度改修1式2 随意契約の予定日 令和8年11月27日3 随意契約によることとする「政府調達に関する協定」の規定上の理由 b「技術的理由による競争の不存在」 4契約を予定している相手方の名称富士通Japan株式会社5 担当部局 〒277-8577 千葉県柏市柏の葉6-5-1国立研究開発法人国立がん研究センター東病院財務経理部柏C財務経理課契約係 電話04-7133-1111

Business Signal

Business Relevance

Use this notice for preparation or market research; it does not establish an open opportunity to submit a bid now.

  • Product fit: Potential
  • Current-case feasibility: Not applicable
  • Evidence confidence: Low
  • Supply-chain security: Unknown

Participation fit

This procedure is classified as sole-source and is not an open competitive tender. Direct participation is not applicable, but the notice may indicate existing government demand and active relevant vendors in Japan.

JBid analysis. Interpretations and questions below do not establish procurement requirements; consult the official documents for those requirements.

This page is based on the official Kanpo tender notice, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.

JBid is a beta technology-procurement intelligence service by I.J. Do.

Back to daily list